Short Interest in Pluri Inc. (NASDAQ:PLUR) Grows By 59.8%
by Danessa Lincoln · The Markets DailyPluri Inc. (NASDAQ:PLUR – Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 14,548 shares, a growth of 59.8% from the December 15th total of 9,104 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average trading volume of 42,290 shares, the days-to-cover ratio is presently 0.3 days. Based on an average trading volume of 42,290 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.2% of the company’s stock are sold short.
Pluri Price Performance
Shares of NASDAQ PLUR traded up $0.17 during mid-day trading on Friday, hitting $3.22. The company’s stock had a trading volume of 13,018 shares, compared to its average volume of 8,829. The company’s fifty day simple moving average is $3.37 and its 200-day simple moving average is $4.28. Pluri has a one year low of $2.82 and a one year high of $7.13. The stock has a market cap of $32.13 million, a price-to-earnings ratio of -0.68 and a beta of 0.66.
Pluri (NASDAQ:PLUR – Get Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.65) earnings per share (EPS) for the quarter. The firm had revenue of $0.32 million during the quarter.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Pluri in a report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, Pluri presently has a consensus rating of “Hold” and an average price target of $12.00.
Get Our Latest Stock Analysis on PLUR
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Pluri stock. Jane Street Group LLC bought a new position in shares of Pluri Inc. (NASDAQ:PLUR – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 10,928 shares of the company’s stock, valued at approximately $47,000. Jane Street Group LLC owned approximately 0.14% of Pluri as of its most recent filing with the Securities & Exchange Commission. 16.59% of the stock is owned by hedge funds and other institutional investors.
Pluri Company Profile
Pluri (NASDAQ:PLUR) is a clinical-stage biotechnology company focused on the development and manufacturing of placental-derived cell therapy products. The company’s proprietary three-dimensional microcarrier expansion platform enables large-scale, off-the-shelf production of PLX (placental expanded) cells, which are being investigated for a range of acute and chronic conditions. Pluri’s approach seeks to combine the regenerative and immunomodulatory properties of stromal cells with a scalable manufacturing process that does not require patient-specific cell harvesting.
Pluri advances its pipeline through internally funded research programs and strategic collaborations with academic institutions and government agencies.